DOCSLIB.ORG

University of Groningen Genome Sequencing and Analysis of The

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
University of Groningen Genome Sequencing and Analysis of The University of Groningen Genome sequencing and analysis of the versatile cell factory Aspergillus niger CBS 513.88 Pel, Herman J.; de Winde, Johannes H.; Archer, David B.; Dyer, Paul S.; Hofmann, Gerald; Schaap, Peter J.; Turner, Geoffrey; Albang, Richard; Albermann, Kaj; Andersen, Mikael R. Published in: Nature Biotechnology DOI: 10.1038/nbt1282 IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below. Document Version Publisher's PDF, also known as Version of record Publication date: 2007 Link to publication in University of Groningen/UMCG research database Citation for published version (APA): Pel, H. J., de Winde, J. H., Archer, D. B., Dyer, P. S., Hofmann, G., Schaap, P. J., Turner, G., Albang, R., Albermann, K., Andersen, M. R., Bendtsen, J. D., Benen, J. A. E., van den Berg, M., Breestraat, S., Caddick, M. X., Contreras, R., Cornell, M., Coutinho, P. M., Danchin, E. G. J., ... de Vries, R. P. (2007). Genome sequencing and analysis of the versatile cell factory Aspergillus niger CBS 513.88. Nature Biotechnology, 25(2), 221-231. https://doi.org/10.1038/nbt1282 Copyright Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons). The publication may also be distributed here under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license. More information can be found on the University of Groningen website: https://www.rug.nl/library/open-access/self-archiving-pure/taverne- amendment. Take-down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum. Download date: 30-09-2021 Supplementary Table 11 Enzymes incorporated in metabolic model but not identified in the genome 1 2-aminoadipate transaminase* 2 2-Dehydro-3-deoxy-D-galactonate aldolase 3 2-keto-3-deoxygluconate aldolase* 4 2-methylisocitrate dehydratase* 5 2-Phenylacetate 5-hydroxylase 6 4-hydroxybenzaldehyde dehydrogenase 7 4-hydroxybenzoate 3-hydroxylase 8 4-hydroxybenzoylformic acid decarboxylase 9 4-hydroxymandelate dehydrogenase 10 4-hydroxyphenylacetic acid monoxygenase 11 Acylglycerol lipase 12 Alanine dehydrogenase (NADPH)* 13 Allophanate hydrolase* 14 Aminocarboxymuconate-semialdehyde decarboxylase 15 Aminodeoxychorismate synthase* 16 Aminomuconate-semialdehyde dehydrogenase 17 Anthranilate 3-monooxygenase (deaminating) 18 Aspartate alpha-decarboxylase 19 B-ketoacyl-ACP synthase (c10,0) 20 Choline sulfotransferase* 21 Chorismate synthase* 22 CMP glycosylase* 23 Cystine reductase 24 DephosphoCoA kinase 25 Dethiobiotin synthetase 26 D-Sorbitol dehydrogenase (acceptor)* 27 Erythrose 4-phosphate phosphatase 28 Erythrose dehydrogenase 29 Erythrose reductase 30 Erythrulose kinase 31 Galactolipid galactosyltransferase 32 Galactose 1-dehydrogenase 33 Gluconate dehydratase* 34 Glutamate synthase (NADPH)* 35 Histamine N-acetyltransferase 36 Histidine decarboxylase 37 Holo-[acyl-carrier-protein] synthase 38 Homoisocitrate dehydrogenase* 39 Hydroxyisourate hydrolase* 40 Inosine diphosphatase* 41 Inosine kinase* 42 Ketotetrose-phosphate aldolase 43 Kynurenine 3-hydroxylase 44 Lactaldehyde dehydrogenase 45 Mannitol kinase* 46 Mannitol-1-phosphatase* 47 Methylglyoxal reductase (MGR I) 48 Methylglyoxal reductase (MGR II) 49 Phenylacetate 2-hydroxylase 50 Phenylacetate hydroxylase 51 Phenylpyruvate decarboxylase 52 Phosphatidate phosphatase 53 Phosphatidylglycerophosphatase* 54 Phospho-pantethiene adenylyltransferase 55 Phosphopantothenate-cysteine decarboxylase 56 Phosphopantothenate-cysteine ligase 57 Pyruvate oxidase* 58 Ribulose reductase* 59 Spermidine dehydrogenase* 60 Spermine synthase* 61 Stearoyl-CoA 15-desaturase* 62 Sulfur dioxygenase 63 Tartrate dehydratase 64 UDPgalactose:1,2-diacylglycerol 3-beta-D-galactosyltransferase 65 UDP-N-acetylglucosamine 4-epimerase * Enzymes from central metabolism..
Load more

Recommended publications
  • (10) Patent No.: US 8119385 B2
    US008119385B2 (12) United States Patent (10) Patent No.: US 8,119,385 B2 Mathur et al. (45) Date of Patent: Feb. 21, 2012 (54) NUCLEICACIDS AND PROTEINS AND (52) U.S. Cl. ........................................ 435/212:530/350 METHODS FOR MAKING AND USING THEMI (58) Field of Classification Search ........................ None (75) Inventors: Eric J. Mathur, San Diego, CA (US); See application file for complete search history. Cathy Chang, San Diego, CA (US) (56) References Cited (73) Assignee: BP Corporation North America Inc., Houston, TX (US) OTHER PUBLICATIONS c Mount, Bioinformatics, Cold Spring Harbor Press, Cold Spring Har (*) Notice: Subject to any disclaimer, the term of this bor New York, 2001, pp. 382-393.* patent is extended or adjusted under 35 Spencer et al., “Whole-Genome Sequence Variation among Multiple U.S.C. 154(b) by 689 days. Isolates of Pseudomonas aeruginosa” J. Bacteriol. (2003) 185: 1316 1325. (21) Appl. No.: 11/817,403 Database Sequence GenBank Accession No. BZ569932 Dec. 17. 1-1. 2002. (22) PCT Fled: Mar. 3, 2006 Omiecinski et al., “Epoxide Hydrolase-Polymorphism and role in (86). PCT No.: PCT/US2OO6/OOT642 toxicology” Toxicol. Lett. (2000) 1.12: 365-370. S371 (c)(1), * cited by examiner (2), (4) Date: May 7, 2008 Primary Examiner — James Martinell (87) PCT Pub. No.: WO2006/096527 (74) Attorney, Agent, or Firm — Kalim S. Fuzail PCT Pub. Date: Sep. 14, 2006 (57) ABSTRACT (65) Prior Publication Data The invention provides polypeptides, including enzymes, structural proteins and binding proteins, polynucleotides US 201O/OO11456A1 Jan. 14, 2010 encoding these polypeptides, and methods of making and using these polynucleotides and polypeptides.
    [Show full text]
  • Orphan Enzymes Could Be an Unexplored Reservoir of New Drug Targets
    Drug Discovery Today Volume 11, Numbers 7/8 April 2006 REVIEWS Reviews GENE TO SCREEN Orphan enzymes could be an unexplored reservoir of new drug targets Olivier Lespinet and Bernard Labedan Institut de Ge´ne´tique et Microbiologie, CNRS UMR 8621, Universite´ Paris Sud, Baˆtiment 400, 91405 Orsay Cedex, France Despite the immense progress of genomics, and the current availability of several hundreds of thousands of amino acid sequences, >39% of well-defined enzyme activities (as represented by enzyme commission, EC, numbers) are not associated with any sequence. There is an urgent need to explore the 1525 orphan enzymes (enzymes having EC numbers without an associated sequence) to bridge the wide gap that separates knowledge of biochemical function and sequence information. Strikingly, orphan enzymes can even be found among enzymatic activities successfully used as drug targets. Here, knowledge of sequence would help to develop molecular-targeted therapies, suppressing many drug-related side-effects. Biology is exploring numerous and diverse fields, each of which discovered before, despite intensive research by thousands of is very complex and difficult to study in its entirety. For many people studying the genetics and biochemistry of Saccharomyces years, immense advances in disclosing molecular functions have cerevisiae over the past 50 years. This observation has been con- been made using reductionist approaches, such as molecular firmed repeatedly, with the cohort of genomes that have been biology. Combining genetic, biophysical and biochemical con- sequenced, at a steady pace, over the past ten years. We now know cepts and methodologies has helped to disclose details of com- that many genes have been missed by reductionist approaches plex molecular mechanisms such as DNA replication.
    [Show full text]
  • Phosphoethanolamine N-Methyl Transferase From
    PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE FROM SPINACH PURIFICATION AND CHARACTERIZATION OF 5-ADENOSYL-L-METHIONINE: PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE FROM SPINACH by DAVID DELMAR SMITH, B.Sc. A Thesis Submitted to the School of Graduate Studies in Partial Fulfilment of the Requirements for the Degree Masters of Science McMaster University (c) Copyright by David Delmar Smith, September 1995 Descriptive Note Masters of Science (1995) McMaster University Biology Hamilton, Ontario TITLE: Purification and Characterization of S-Adenosyi-L-Methionine: Phosphoethanolamine N-Methyltransferase From Spinach AUTHOR: David Delmar Smith, B.Sc. (McMaster University) SUPERVISOR: Dr. Elizabeth A. Weretilnyk NUMBER OF PAGES: xvi, 136 ii ABSTRACT During conditions of osmotic stress, some plants accumulate compatible osmolytes such as glycine betaine or choline-0-sulphate. Choline is required as a precursor for synthesis of both osmolytes and choline is also required by all plants as a component of phospholipids. In the betaine accumulator spinach, choline synthesis requires three sequential N-methylations of phosphoethanolamine (PEA) to generate phosphocholine (PCho), with the first N-methylation being catalyzed by S-adenosyi-L-methionine: PEA N­ methyltransferase (PEAMeT). Choline synthesis and, more particularly the activity of PEAMeT, are up-regulated by salinity (Summers and Weretilnyk, 1993). This thesis reports on the partial purification and preliminary characterization of PEAMeT from spinach. A variety of column chromatography matrices including DEAE Sepharose, phenyl Sepharose, w-aminohexyl agarose, hydroxylapatite, phenyl Superose, Mono Q and adenosine agarose, have been used to purify PEAMeT. A 5403- 1 1 fold purified preparation yielded a specific activity of 189 nmol· min- • mg- protein. SDS-PAGE analysis of this preparation revealed a number of polypeptide bands but only one which photoaffinity cross-linked to [3 H]SAM.
    [Show full text]
  • Der Jasmonsäure-Metabolismus in Tomate (Solanum Lycopersicum
    Literaturverzeichnis 6 Literaturverzeichnis 141 Literaturverzeichnis Afitlhile, M. M.; Fukushige, H.; Nishimura, M.; Hildebrand, D. F. (2005): A defect in glyoxysomal fatty acid ß-oxidation reduces jasmonic acid accumulation in Arabidopsis. Plant Physiology and Biochemistry 43: 603-609. Ahn, J. A.; Miller, D.; Winter, V. J.; Banfield, M. J.; Lee, J. H.; Yoo, S. Y.; Henz, S. R.; Brady, R. L.; Wei- gel, D. (2006): A divergent external loop confers antagonistic activity on floral regulators FT and TFL1. EMBO Journal 25: 605–614. Allen, K. D.; Sussex, I. M. (1996): Falsiflora and anantha control early stages of floral meristem develop- ment in tomato (Lycopersicon esculentum Mill). Planta 200: 254–264. Ananvoranich, S.; Varin, L.; Gulick, P.; Ibrahim, R. K. (1994) Cloning and regulation of flavonol 3-sul- fotransferasein cell suspension cultures of Flaveria bidentis. Plant Physiol. 106: 485-491. Andersson, M. X.; Hamberg, M.; Kourtchenko, O.; Brunnstrom, A.; McPhail, K. L.; Gerwick, W. H.; Gobel, C., Feussner, I.; Ellerstrom, M. (2006): Oxylipin profiling of the hypersensitive response in Arabidopsis thaliana: formation of a novel oxo-phytodienoic acid-containing galactolipid, Arabidopside E. Journal of Biological Chemistry 281: 31528-31537. Atherton, J. G.; Harris, J. (1986): The tomato crop. London: Chapman and Hall. Barron, D.; Varin, L.; Ibrahim, R. K.; Harborne, J. B.; Williams, C. A. (1988): Sulphated flavonoids – an update. Phytochemistry 27: 2375-2395. Bäurle, I.; Dean, C. (2006): The timing of developmental transitions in plants. Cell 125: 655-664. Bell, P. R. (1992): Green plants: their origin and diversity. Cambridge: Cambridge University Press. Bergey, D. R.; Howe, G. A.; Ryan, C.
    [Show full text]
  • Structural and Biochemical Studies of Sulphotransferase 18 From
    Structural and biochemical studies of sulphotransferase 18 from Arabidopsis thaliana explain its substrate specificity and reaction mechanism Hirschmann, Felix; Krause, Florian; Baruch, Petra; Chizhov, Igor; Mueller, Jonathan Wolf; Manstein, Dietmar J; Papenbrock, Jutta; Fedorov, Roman DOI: 10.1038/s41598-017-04539-2 License: Creative Commons: Attribution (CC BY) Document Version Publisher's PDF, also known as Version of record Citation for published version (Harvard): Hirschmann, F, Krause, F, Baruch, P, Chizhov, I, Mueller, JW, Manstein, DJ, Papenbrock, J & Fedorov, R 2017, 'Structural and biochemical studies of sulphotransferase 18 from Arabidopsis thaliana explain its substrate specificity and reaction mechanism', Scientific Reports, vol. 7, 4160. https://doi.org/10.1038/s41598-017-04539- 2 Link to publication on Research at Birmingham portal General rights Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes permitted by law. •Users may freely distribute the URL that is used to identify this publication. •Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private study or non-commercial research. •User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?) •Users may not further distribute the material nor use it for the purposes of commercial gain. Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
    [Show full text]
  • The Role of Plant-Derived Quaternary Ammonium Compounds, Including Carnitine and Choline-O-Sulfate, on the Biology of the Plant
    Iowa State University Capstones, Theses and Graduate Theses and Dissertations Dissertations 2015 The oler of plant-derived quaternary ammonium compounds, including carnitine and choline-O- sulfate, on the biology of the plant pathogen Pseudomonas syringae and its interactions with the host species Phaseolus vulgaris Michael David Millican Iowa State University Follow this and additional works at: https://lib.dr.iastate.edu/etd Part of the Agriculture Commons, Microbiology Commons, and the Plant Pathology Commons Recommended Citation Millican, Michael David, "The or le of plant-derived quaternary ammonium compounds, including carnitine and choline-O-sulfate, on the biology of the plant pathogen Pseudomonas syringae and its interactions with the host species Phaseolus vulgaris" (2015). Graduate Theses and Dissertations. 14948. https://lib.dr.iastate.edu/etd/14948 This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. The role of plant-derived quaternary ammonium compounds, including carnitine and choline-O-sulfate, on the biology of the plant pathogen Pseudomonas syringae and its interactions with the host species Phaseolus vulgaris by Michael D. Millican A dissertation submitted to the graduate faculty in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY Major: Microbiology Program of Study Committee: Gwyn Beattie, Major Professor Thomas Bobik Qijing Zhang Byron Brehm-Stecher Larry Halverson Iowa State University Ames, Iowa 2015 Copyright © Michael D.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2012/0266329 A1 Mathur Et Al
    US 2012026.6329A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2012/0266329 A1 Mathur et al. (43) Pub. Date: Oct. 18, 2012 (54) NUCLEICACIDS AND PROTEINS AND CI2N 9/10 (2006.01) METHODS FOR MAKING AND USING THEMI CI2N 9/24 (2006.01) CI2N 9/02 (2006.01) (75) Inventors: Eric J. Mathur, Carlsbad, CA CI2N 9/06 (2006.01) (US); Cathy Chang, San Marcos, CI2P 2L/02 (2006.01) CA (US) CI2O I/04 (2006.01) CI2N 9/96 (2006.01) (73) Assignee: BP Corporation North America CI2N 5/82 (2006.01) Inc., Houston, TX (US) CI2N 15/53 (2006.01) CI2N IS/54 (2006.01) CI2N 15/57 2006.O1 (22) Filed: Feb. 20, 2012 CI2N IS/60 308: Related U.S. Application Data EN f :08: (62) Division of application No. 1 1/817,403, filed on May AOIH 5/00 (2006.01) 7, 2008, now Pat. No. 8,119,385, filed as application AOIH 5/10 (2006.01) No. PCT/US2006/007642 on Mar. 3, 2006. C07K I4/00 (2006.01) CI2N IS/II (2006.01) (60) Provisional application No. 60/658,984, filed on Mar. AOIH I/06 (2006.01) 4, 2005. CI2N 15/63 (2006.01) Publication Classification (52) U.S. Cl. ................... 800/293; 435/320.1; 435/252.3: 435/325; 435/254.11: 435/254.2:435/348; (51) Int. Cl. 435/419; 435/195; 435/196; 435/198: 435/233; CI2N 15/52 (2006.01) 435/201:435/232; 435/208; 435/227; 435/193; CI2N 15/85 (2006.01) 435/200; 435/189: 435/191: 435/69.1; 435/34; CI2N 5/86 (2006.01) 435/188:536/23.2; 435/468; 800/298; 800/320; CI2N 15/867 (2006.01) 800/317.2: 800/317.4: 800/320.3: 800/306; CI2N 5/864 (2006.01) 800/312 800/320.2: 800/317.3; 800/322; CI2N 5/8 (2006.01) 800/320.1; 530/350, 536/23.1: 800/278; 800/294 CI2N I/2 (2006.01) CI2N 5/10 (2006.01) (57) ABSTRACT CI2N L/15 (2006.01) CI2N I/19 (2006.01) The invention provides polypeptides, including enzymes, CI2N 9/14 (2006.01) structural proteins and binding proteins, polynucleotides CI2N 9/16 (2006.01) encoding these polypeptides, and methods of making and CI2N 9/20 (2006.01) using these polynucleotides and polypeptides.
    [Show full text]
  • All Enzymes in BRENDA™ the Comprehensive Enzyme Information System
    All enzymes in BRENDA™ The Comprehensive Enzyme Information System http://www.brenda-enzymes.org/index.php4?page=information/all_enzymes.php4 1.1.1.1 alcohol dehydrogenase 1.1.1.B1 D-arabitol-phosphate dehydrogenase 1.1.1.2 alcohol dehydrogenase (NADP+) 1.1.1.B3 (S)-specific secondary alcohol dehydrogenase 1.1.1.3 homoserine dehydrogenase 1.1.1.B4 (R)-specific secondary alcohol dehydrogenase 1.1.1.4 (R,R)-butanediol dehydrogenase 1.1.1.5 acetoin dehydrogenase 1.1.1.B5 NADP-retinol dehydrogenase 1.1.1.6 glycerol dehydrogenase 1.1.1.7 propanediol-phosphate dehydrogenase 1.1.1.8 glycerol-3-phosphate dehydrogenase (NAD+) 1.1.1.9 D-xylulose reductase 1.1.1.10 L-xylulose reductase 1.1.1.11 D-arabinitol 4-dehydrogenase 1.1.1.12 L-arabinitol 4-dehydrogenase 1.1.1.13 L-arabinitol 2-dehydrogenase 1.1.1.14 L-iditol 2-dehydrogenase 1.1.1.15 D-iditol 2-dehydrogenase 1.1.1.16 galactitol 2-dehydrogenase 1.1.1.17 mannitol-1-phosphate 5-dehydrogenase 1.1.1.18 inositol 2-dehydrogenase 1.1.1.19 glucuronate reductase 1.1.1.20 glucuronolactone reductase 1.1.1.21 aldehyde reductase 1.1.1.22 UDP-glucose 6-dehydrogenase 1.1.1.23 histidinol dehydrogenase 1.1.1.24 quinate dehydrogenase 1.1.1.25 shikimate dehydrogenase 1.1.1.26 glyoxylate reductase 1.1.1.27 L-lactate dehydrogenase 1.1.1.28 D-lactate dehydrogenase 1.1.1.29 glycerate dehydrogenase 1.1.1.30 3-hydroxybutyrate dehydrogenase 1.1.1.31 3-hydroxyisobutyrate dehydrogenase 1.1.1.32 mevaldate reductase 1.1.1.33 mevaldate reductase (NADPH) 1.1.1.34 hydroxymethylglutaryl-CoA reductase (NADPH) 1.1.1.35 3-hydroxyacyl-CoA
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2015/0240226A1 Mathur Et Al
    US 20150240226A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2015/0240226A1 Mathur et al. (43) Pub. Date: Aug. 27, 2015 (54) NUCLEICACIDS AND PROTEINS AND CI2N 9/16 (2006.01) METHODS FOR MAKING AND USING THEMI CI2N 9/02 (2006.01) CI2N 9/78 (2006.01) (71) Applicant: BP Corporation North America Inc., CI2N 9/12 (2006.01) Naperville, IL (US) CI2N 9/24 (2006.01) CI2O 1/02 (2006.01) (72) Inventors: Eric J. Mathur, San Diego, CA (US); CI2N 9/42 (2006.01) Cathy Chang, San Marcos, CA (US) (52) U.S. Cl. CPC. CI2N 9/88 (2013.01); C12O 1/02 (2013.01); (21) Appl. No.: 14/630,006 CI2O I/04 (2013.01): CI2N 9/80 (2013.01); CI2N 9/241.1 (2013.01); C12N 9/0065 (22) Filed: Feb. 24, 2015 (2013.01); C12N 9/2437 (2013.01); C12N 9/14 Related U.S. Application Data (2013.01); C12N 9/16 (2013.01); C12N 9/0061 (2013.01); C12N 9/78 (2013.01); C12N 9/0071 (62) Division of application No. 13/400,365, filed on Feb. (2013.01); C12N 9/1241 (2013.01): CI2N 20, 2012, now Pat. No. 8,962,800, which is a division 9/2482 (2013.01); C07K 2/00 (2013.01); C12Y of application No. 1 1/817,403, filed on May 7, 2008, 305/01004 (2013.01); C12Y 1 1 1/01016 now Pat. No. 8,119,385, filed as application No. PCT/ (2013.01); C12Y302/01004 (2013.01); C12Y US2006/007642 on Mar. 3, 2006.
    [Show full text]
  • Structural and Biochemical Studies of Sulphotransferase 18 From
    University of Birmingham Structural and biochemical studies of sulphotransferase 18 from Arabidopsis thaliana explain its substrate specificity and reaction mechanism Hirschmann, Felix; Krause, Florian; Baruch, Petra; Chizhov, Igor; Mueller, Jonathan Wolf; Manstein, Dietmar J; Papenbrock, Jutta; Fedorov, Roman DOI: 10.1038/s41598-017-04539-2 License: Creative Commons: Attribution (CC BY) Document Version Publisher's PDF, also known as Version of record Citation for published version (Harvard): Hirschmann, F, Krause, F, Baruch, P, Chizhov, I, Mueller, JW, Manstein, DJ, Papenbrock, J & Fedorov, R 2017, 'Structural and biochemical studies of sulphotransferase 18 from Arabidopsis thaliana explain its substrate specificity and reaction mechanism', Scientific Reports, vol. 7, 4160. https://doi.org/10.1038/s41598-017-04539- 2 Link to publication on Research at Birmingham portal General rights Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes permitted by law. •Users may freely distribute the URL that is used to identify this publication. •Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private study or non-commercial research. •User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?) •Users may not further distribute the material nor use it for the purposes of commercial gain. Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
    [Show full text]
  • Single-Cell Genomics Reveals Complex Carbohydrate Degradation Patterns in Poribacterial Symbionts of Marine Sponges
    The ISME Journal (2013) 7, 2287–2300 & 2013 International Society for Microbial Ecology All rights reserved 1751-7362/13 www.nature.com/ismej ORIGINAL ARTICLE Single-cell genomics reveals complex carbohydrate degradation patterns in poribacterial symbionts of marine sponges Janine Kamke1, Alexander Sczyrba2,3, Natalia Ivanova2, Patrick Schwientek2, Christian Rinke2, Kostas Mavromatis2, Tanja Woyke2 and Ute Hentschel1 1Department of Botany II, Julius-von-Sachs Institute for Biological Sciences, University of Wuerzburg, Wuerzburg, Germany; 2Department of Energy Joint Genome Institute, Walnut Creek, CA, USA and 3Center for Biotechnology, Bielefeld University, Bielefeld, Germany Many marine sponges are hosts to dense and phylogenetically diverse microbial communities that are located in the extracellular matrix of the animal. The candidate phylum Poribacteria is a predominant member of the sponge microbiome and its representatives are nearly exclusively found in sponges. Here we used single-cell genomics to obtain comprehensive insights into the metabolic potential of individual poribacterial cells representing three distinct phylogenetic groups within Poribacteria. Genome sizes were up to 5.4 Mbp and genome coverage was as high as 98.5%. Common features of the poribacterial genomes indicated that heterotrophy is likely to be of importance for this bacterial candidate phylum. Carbohydrate-active enzyme database screening and further detailed analysis of carbohydrate metabolism suggested the ability to degrade diverse carbohydrate sources likely originating from seawater and from the host itself. The presence of uronic acid degradation pathways as well as several specific sulfatases provides strong support that Poribacteria degrade glycosaminoglycan chains of proteoglycans, which are important components of the sponge host matrix. Dominant glycoside hydrolase families further suggest degradation of other glycoproteins in the host matrix.
    [Show full text]
  • Supplementary Material (ESI) for Natural Product Reports
    Electronic Supplementary Material (ESI) for Natural Product Reports. This journal is © The Royal Society of Chemistry 2014 Supplement to the paper of Alexey A. Lagunin, Rajesh K. Goel, Dinesh Y. Gawande, Priynka Pahwa, Tatyana A. Gloriozova, Alexander V. Dmitriev, Sergey M. Ivanov, Anastassia V. Rudik, Varvara I. Konova, Pavel V. Pogodin, Dmitry S. Druzhilovsky and Vladimir V. Poroikov “Chemo- and bioinformatics resources for in silico drug discovery from medicinal plants beyond their traditional use: a critical review” Contents PASS (Prediction of Activity Spectra for Substances) Approach S-1 Table S1. The lists of 122 known therapeutic effects for 50 analyzed medicinal plants with accuracy of PASS prediction calculated by a leave-one-out cross-validation procedure during the training and number of active compounds in PASS training set S-6 Table S2. The lists of 3,345 mechanisms of action that were predicted by PASS and were used in this study with accuracy of PASS prediction calculated by a leave-one-out cross-validation procedure during the training and number of active compounds in PASS training set S-9 Table S3. Comparison of direct PASS prediction results of known effects for phytoconstituents of 50 TIM plants with prediction of known effects through “mechanism-effect” and “target-pathway- effect” relationships from PharmaExpert S-79 S-1 PASS (Prediction of Activity Spectra for Substances) Approach PASS provides simultaneous predictions of many types of biological activity (activity spectrum) based on the structure of drug-like compounds. The approach used in PASS is based on the suggestion that biological activity of any drug-like compound is a function of its structure.
    [Show full text]